Table of contents
Take control of your serialized supply chain and unlock the value of serialization data.
DSCSA 2023 regulations will introduce new challenges for drug manufacturers because serialized product data will need to be verified by downstream trading partners, significantly increasing the requirement for a complete end-to-end view of serialized operations.
TraceLink Serialized Product Intelligence can help. Download this solution brief to learn how this advanced operational reporting solution helps ensure timely delivery of serialized medicines while reducing operational costs. With Serialized Product Intelligence, you can:
- Improve visibility by transforming events and compliance requirements into visual reports.
- Empower business users and other stakeholders by simplifying data querying and visualization.
- Bolster product availability by accelerating the resolution of issues like serialization discrepancies arising from DSCSA 2023 verifications.
Download the solution brief today and see how you can get real-time, actionable visibility across your end-to-end serialized drug supply chain.
